When EGFR was transiently silenced in B16F10 cells via the introduction of small interfering RNA (siRNA) or by adding the recombinant chimeric EGFR monoclonal antibody Cetuximab in the presence of ALOC-EO, melanoma growth was inhibited. The gene discussed is EGFR; the disease is melanoma.